Skip to main content
Equibles
PCVX logo

PCVX · Vaxcyte, Inc. · Webcasts, Transcripts & Audio

Track PCVX — free

Use PCVX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PCVX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$56.48 +0.43 (+0.77%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$8.36B
Shares
148.81M
Volume · Oct 2 2.4M Avg daily vol (3M) 1.15M

Vaxcyte, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Vaxcyte, Inc. (PCVX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-08
Vaxcyte, Inc. (PCVX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
Vaxcyte, Inc. (PCVX) Q1 2026 Earnings Call
Diluted EPS
$-2.30
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Confident tone VAX-31 Adult Phase III (Opus) Program Infant Program (VAX-31 / VAX-24) Competitive Positioning vs. PCV20 and PCV21
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Vaxcyte, Inc. (PCVX) Q3 2025 Earnings Call
Diluted EPS
$-1.56
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Vaxcyte, Inc. (PCVX) Q2 2025 Earnings Call
Diluted EPS
$-1.22
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Vaxcyte, Inc. (PCVX) Q1 2025 Earnings Call
Diluted EPS
$-1.04
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Vaxcyte, Inc. (PCVX) Q4 2024 Earnings Call Transcript
Confident tone Infant pipeline and VAX-24/VAX-31 infant programs VAX-31 clinical progress and Phase 3 advancement ACIP recommendations and preferred status
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Vaxcyte, Inc. (PCVX) Q3 2024 Earnings Call
Diluted EPS
$-0.83
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Vaxcyte, Inc. (PCVX) Q1 2024 Earnings Call
Diluted EPS
$-0.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Vaxcyte, Inc. (PCVX) Q4 2023 Earnings Call Transcript
Confident tone VAX-24 adult program VAX-31 adult program Regulatory and competitive landscape (V116, ACIP)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q4
2023-04-17
Vaxcyte, Inc. (PCVX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-02-28
Vaxcyte, Inc. (PCVX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-29
Vaxcyte, Inc. (PCVX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–13 of 13 webcasts
Key facts CIK 1649094 CUSIP 92243G108 13F (30d) 8 filings 8 filers Visit website Investor relations